233 related articles for article (PubMed ID: 38558851)
1. Intestinal microbiota and biliary system diseases.
Wang H; Gong J; Chen J; Zhang W; Sun Y; Sun D
Front Cell Infect Microbiol; 2024; 14():1362933. PubMed ID: 38558851
[TBL] [Abstract][Full Text] [Related]
2. Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
Pereira P; Aho V; Arola J; Boyd S; Jokelainen K; Paulin L; Auvinen P; Färkkilä M
PLoS One; 2017; 12(8):e0182924. PubMed ID: 28796833
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota in biliary diseases.
Xia Q; Liu Q; Ma X
Curr Opin Gastroenterol; 2023 Mar; 39(2):95-102. PubMed ID: 36821457
[TBL] [Abstract][Full Text] [Related]
4. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
6. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
[TBL] [Abstract][Full Text] [Related]
7. The gut microbial influence on cholestatic liver disease.
Kummen M; Hov JR
Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
[TBL] [Abstract][Full Text] [Related]
8. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
9. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
10. Definition and pathology of primary sclerosing cholangitis.
Nakanuma Y; Harada K; Katayanagi K; Tsuneyama K; Sasaki M
J Hepatobiliary Pancreat Surg; 1999; 6(4):333-42. PubMed ID: 10664278
[TBL] [Abstract][Full Text] [Related]
11. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
[TBL] [Abstract][Full Text] [Related]
13. The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts.
Hov JR; Karlsen TH
Semin Liver Dis; 2017 Nov; 37(4):314-331. PubMed ID: 29272894
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
[TBL] [Abstract][Full Text] [Related]
17. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
Sebode M; Weiler-Normann C; Liwinski T; Schramm C
Front Immunol; 2018; 9():609. PubMed ID: 29636752
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the bile microbiome in primary sclerosing cholangitis.
Liwinski T; Zenouzi R; John C; Ehlken H; Rühlemann MC; Bang C; Groth S; Lieb W; Kantowski M; Andersen N; Schachschal G; Karlsen TH; Hov JR; Rösch T; Lohse AW; Heeren J; Franke A; Schramm C
Gut; 2020 Apr; 69(4):665-672. PubMed ID: 31243055
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM
Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]